Clinical trial
A Phase II Study on Preoperative Administration of Gleevec in Patients With Initially Non-Resectable Gastrointestinal Stromal Tumor
NCT00290485 is registered in ClinicalTrials.gov with Maisonneuve-Rosemont Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study on Preoperative Administration of Gleevec in Patients With Initially Non-Resectable Gastrointestinal Stromal Tumor
- Lead sponsor
- Maisonneuve-Rosemont Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- August 31, 2005
- Completion date
- Not reported
- Enrollment
- 50
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.